Deep Brain Stimulators (DBS) Market Size, Share, and Trends Analysis by Region, Product (Single Channel and Dual Channel), Application (Parkinson’s Disease, Epilepsy, Essential Tremor, Obsessive Compulsive Disorder, and Others), End-user (Hospitals, Neurology Clinics, and Others), and Segment Forecast, 2022-2027

Pages: 79 Published: November 21, 2022 Report Code: GDMD-SC-MR006

The deep brain stimulators market size was valued at US$ 1.18 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 12.1% during 2022-2027. The major factors contributing to the market growth includes introduction of technologically advanced deep brain stimulators and rising burden of neurological disorders. However, factors such as the complications associated with deep brain stimulation may hinder the market in focus growth. On contrary, increasing public-private initiatives for the development of efficient and advanced deep brain stimulators and growing awareness about early diagnosis and treatment of neurological diseases will boost the deep brain stimulators market growth.

Deep Brain Stimulators Market Overview

Deep Brain Stimulators Market Overview

View Sample Report for Additional Insights on the Deep Brain Stimulators Market Forecast, Download a Free Report Sample

Key players operating in the market are involved in extensive R&D for the development and introduction of novel devices with directional deep brain stimulation technology. The introduction of such innovative products is anticipated to significantly support market growth. In June 2021, Medtronic plc, one of the leading medical device companies globally, received the US Food and Drug Administration (FDA) approval for SenSight, a directional lead system developed for deep brain stimulation therapy. In January 2021, the US FDA approved Boston Scientific Corporation’s fourth-generation Vercise Genus Deep Brain Stimulation System.

Moreover, advancements in in software’s have further empowered a number of programming strategies to be deployed to support in enhancing the efficacy while diminishing stimulation-induced side effects and also by improving the battery life. In April 2022, Boston Scientific Corporation, an US-based medical device company, received the US FDA clearance for Vercise Neural Navigator with STIMVIEW XT, its newest image guided programming software. This advanced software allows clinicians to provide improved personalised therapy to each patient, as per their requirements, by providing patient-specific 3D visualisation of the anatomy.

Mounting burden of different neurological diseases around the globe is also anticipated to create a high demand for innovative treatment approaches such as deep brain stimulators, thus supporting the market’s growth over the forecast period.

Deep Brain Stimulators Market Segmentation by Product

The deep brain stimulators market can be segmented into single channel and dual channel based on product. The single channel segment accounted for the largest market share in 2021. Single channel deep brain stimulation devices provides a safe procedure and significant results in motor issues. Early implantable pulse generators were single channel devices, which meant that one implantable pulse generator could only accommodate one deep brain stimulation lead, necessitating the use of two separate implantable pulse generators for bilateral lead implantation. Dual channel segment is anticipated to show a considerable growth over the forecast period owing to some advantages related to it. Implanting a dual channel stimulator requires only one procedure. In addition, dual channel neurostimulators stimulate two separate deep brain stimulation leads, allowing for bilateral therapy. Moreover, the dual channel has the added advantage of only requiring one battery to be replaced or charged.

Deep Brain Stimulators Market Share by Product, 2021 (%)

Deep Brain Stimulators Market Share by Product, 2021 (%)

Fetch Sample PDF for Segment-Specific Revenues and Shares, Download a Free Report Sample

Deep Brain Stimulators Market Segmentation by Application

The deep brain stimulators market can be segmented into Parkinson’s disease, epilepsy, essential tremor, obsessive compulsive disorder, and others based on application. The Parkinson’s disease segment accounted for the largest market share in 2021. Parkinson’s disease is posing an increasing threat to public health. In recent years, this disease has seen the fastest increase in prevalence and disability among neurological disorders, and it has emerged as one of the leading causes of disability worldwide. Such, a high burden related to the diseases is anticipated to create high demand for its treatment approaches including the deep brain stimulating devices. In addition, introduction of advanced deep brain stimulation devices for Parkinson’s disease is anticipated to be another prominent factor driving the market growth. For instance, in January 2020, the US FDA granted Abbott Laboratories an expanded indication approval for Abbott’s Infinity DBS, a directional deep brain stimulation system indicated for the treatment of patient suffering from Parkinson’s disease.

Deep Brain Stimulators Market Share by Application, 2021 (%)

Deep Brain Stimulators Market Share by Application, 2021 (%)

Fetch Sample PDF for Segment-Specific Revenues and Shares, Download a Free Report Sample

Deep Brain Stimulators Market Analysis by Region

North America leads the deep brain stimulators market in 2021, owing to its high prevalence of neurological diseases and the easy accessibility to treatments in the region. According to National Neurological Conditions Surveillance System, for millions of people of all ages in the US, neurological illnesses and ailments have significant and often disastrous implications. The European market is witnessing significant growth in deep brain stimulators market. The European market majorly comprises Western Europe and Eastern Europe. Western Europe consists of Germany, France, the UK, Italy, Spain, and the Rest of Western Europe. Major factors influencing the growth of the market include the presence of prominent manufacturers and distributors, technological advancements and introduction of innovative products and lifestyle changes.

Deep Brain Stimulators Market Share by Region, 2021 (%)

Deep Brain Stimulators Market Share by Region, 2021 (%)

View Sample Report for Additional Deep Brain Stimulators Market Insights, Download a Free Report Sample

Deep Brain Stimulators Market - Competitive Landscape

Key players operating in the deep brain stimulators market are more focused on organic growth strategies like new product launches and enhancement of existing products, to improve their competitive position and gain further market share. For instance, during 2020 and 2021, key players including Abbott (St. Jude Medical Inc), Aleva Neurotherapeutics SA, Boston Scientific Corporation, Medtronic, Nexstim, and Newronika S.P.A.,have expanded their portfolios by launching a new deep brain stimulator application or updating the existing product with enhanced features like Magnetic Resonance Imaging (MRI) compatibility.

Leading Players in the Deep Brain Stimulators Market

  • Abbott Laboratories (St. Jude Medical Inc.)
  • Aleva Neurotherapeutics SA
  • Beijing Pins Medical Co. Ltd.
  • Boston Scientific Corp.
  • Functional Neuromodulation Ltd.
  • LivaNova Plc
  • Medtronic Plc
  • Newronika S.p.A.
  • Nexstim Plc
  • Renishaw Plc
  • Other players

Other Deep Brain Stimulators Market Vendors Mentioned

Abbott Laboratories (St. Jude Medical Inc.), Aleva Neurotherapeutics SA, Beijing Pins Medical Co. Ltd., Boston Scientific Corp., Functional Neuromodulation Ltd., LivaNova Plc, Medtronic Plc, Newronika S.p.A., Nexstim Plc, Renishaw Plc, among others.

To Know More About Leading Deep Brain Stimulators Market Players, Download a Free Report Sample

Deep Brain Stimulators Market Research Overview

Market Size (2021) US$ 1.18 billion
Market Size (2027) US$ 2.32 billion
CAGR 12.1%
Forecast Period 2022-2027
Historic Period 2020-2021
Report Scope & Coverage Revenue Forecast, Segmental Market Share, Trends, Drivers, and Challenges, Segmental Forecast, Pipeline Products
Product Segment Single Channel, Dual Channel
Application Segment Parkinson’s Disease, Epilepsy, Essential Tremor, Obsessive Compulsive Disorder, Others
End-user Segment Hospitals, Neurology Clinics, Others
Key Companies Abbott Laboratories (St. Jude Medical Inc), Aleva Neurotherapeutics SA, Beijing Pins Medical Co. Ltd., Boston Scientific Corp., Functional Neuromodulation Ltd., LivaNova Plc, Medtronic Plc, Newronika S.p.A., Nexstim Plc, Renishaw Plc

 

Deep Brain Stimulators Market Scope

GlobalData Plc has segmented the deep brain stimulators market report by product, application, end-user, and region:

Deep Brain Stimulators Product Outlook (Revenue, USD Million, 2020-2027)

  • Single Channel
  • Dual Channel

Deep Brain Stimulators Application Outlook (Revenue, USD Million, 2020-2027)

  • Parkinson’s Disease
  • Epilepsy
  • Essential Tremor
  • Obsessive Compulsive Disorder
  • Others

Deep Brain Stimulators End Users Outlook (Revenue, USD Million, 2020-2027)

  • Hospitals
  • Neurology Clinics
  • Others

Deep Brain Stimulators Regional Outlook (Revenue, USD Million, 2020-2027)

  • North America
  • US
  • Canada  
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia Pacific
  • China
  • Japan
  • India
  • Rest of Asia Pacific
  • ROW

The market intelligence report provides an in-depth analysis of the following –

  • Deep brain stimulators market outlook: analysis as well as historical figures and forecasts of revenue opportunities from the product, application, and end users segments.
  • The competitive landscape: an examination of the positioning of leading players in the deep brain stimulators market.
  • Company snapshots: analysis of the market position of leading players in the deep brain stimulators market.

Reasons to Buy

  • This market intelligence report offers a thorough, forward-looking analysis of the global deep brain stimulators market and key opportunities in a concise format to help executives build proactive and profitable growth strategies.
  • Accompanying GlobalData’s Forecast products, the report examines the assumptions and drivers behind ongoing and upcoming trends in deep brain stimulators market.

The report also highlights key product, application, and end users segments.

  • With different charts and tables, the report is designed for an executive-level audience, boasting presentation quality.
  • The report provides an easily digestible market assessment for decision-makers built around in-depth information gathered from market players, which enables executives to quickly get up to speed with the current and emerging trends in deep brain stimulators market.

Key Players

Abbott (St. Jude Medical Inc.)
Aleva Neurotherapeutics SA
Beijing Pins Medical Co. Ltd.
Boston Scientific Corp.
Functional Neuromodulation Ltd.
LivaNova Plc
Medtronic Plc
Newronika S.P.A.
Nexstim Plc
Renishaw Plc

Table of Contents

CHAPTER 01 Executive Summary

1.1 Deep Brain Stimulators Market Snapshot

1.2 Deep Brain Stimulators Market- Key Findings

CHAPTER 02 Market Landscape

2.1 Market Definition

2.2 Market Scope and Segmentation

CHAPTER 03 Deep Brain Stimulators – Market Dynamics

3.1 Deep Brain Stimulators – Trends, Drivers, and Challenges

3.1.1 Deep Brain Stimulators – Market Trends

3.1.1.1 Increasing Partnerships And Collaborations

3.1.1.2 Rising Awareness About Neurological Disorders And Deep Brain Stimulators

3.1.2 Deep Brain Stimulators – Market Drivers

3.1.2.1 Technological Advancements and Introduction of Innovative Products

3.1.2.2 Increasing Public-Private Investments and Initiatives for Deep Brain Stimulation

3.1.2.3 Increasing incidences of neurological diseases

3.1.3 Deep Brain Stimulators – Market Challenges

3.1.3.1 Complications associated with deep brain stimulation

3.1.3.2 lack of skilled and trained professionals

3.2 Deep Brain Stimulators – Product Approvals

3.3 Deep Brain Stimulators Market Structure – PORTER’s Analysis

3.4 Deep Brain Stimulators – Impact of COVID-19 and Russia-Ukraine War

3.5 Deep Brain Stimulators – Regulatory Scenario

3.5.1 European countries

3.5.2 US

3.5.3 Japan

3.5.4 LATAM countries

3.5.5 MEA countries

3.6 Deep Brain Stimulators – Clinical Trial and Pipeline Assessment

3.6.1 Deep Brain Stimulators – Pipeline Products by Stage of Development

3.6.2 Deep Brain Stimulators – Pipeline Products by Territory

3.6.3 Deep Brain Stimulators – Pipeline Products by Regulatory Path

3.6.4 Deep Brain Stimulators – Ongoing Clinical trials

3.6.5 Deep Brain Stimulators – Pipeline Products by Players

CHAPTER 04 Global Deep Brain Stimulators Revenue Opportunity

4.1 Global Deep Brain Stimulators Market

CHAPTER 05 Deep Brain Stimulators Product Outlook

5.1 Deep Brain Stimulators – Product Deep Dive

5.1.1 Single Channel

5.1.2 Dual Channel

CHAPTER 06 Deep Brain Stimulators Application Outlook

6.1 Deep Brain Stimulators – Application Deep Dive

6.1.1 Parkinson’s Disease

6.1.2 Epilepsy

6.1.3 Essential Tremor

6.1.4 Obsessive Compulsive Disorder

6.1.5 Others

CHAPTER 07 Deep Brain Stimulators End User Outlook

7.1 Deep Brain Stimulators – End User Deep Dive

7.1.1 Hospitals

7.1.2 Neurology Clinics

7.1.3 Others

CHAPTER 08 Deep Brain Stimulators by Regional Outlook

8.1 Deep Brain Stimulators – Regional Deep Dive

8.1.1 North America

8.1.2 Europe

8.1.3 Asia-Pacific

8.1.4 ROW

CHAPTER 09 Competitive Landscape

9.1.1 Product Heat Map Analysis

9.1.2 Key Players Strategy Outlook

9.1.3 Recent Product Launches & approvals

9.1.4 Recent mergers, acquisitions, Public-Private Partnerships

CHAPTER 010 Deep Brain Stimulators Vendor Snapshot

10.1.1 Company snapshot: Abbott Laboratories (St. Jude Medical Inc)

10.1.2 Company snapshot: Aleva Neurotherapeutics SA

10.1.3 Company snapshot: Beijing Pins Medical Co. Ltd.

10.1.4 Company snapshot: Boston Scientific Corp.

10.1.5 Company snapshot: Functional Neuromodulation Ltd.

10.1.6 Company snapshot: LivaNova Plc

10.1.7 Company snapshot: Newronika S.p.A.

10.1.8 Company snapshot: Medtronic Plc

10.1.9 Company snapshot: Renishaw Plc

10.1.10 Company snapshot: Nexstim Plc

10.1.11 Neuropace Inc.

10.1.12 Nevro Corp.

10.1.13 Neuronetics Inc.

10.1.14 SceneRay Co. Ltd.

10.1.15 Cyberonics Inc.

CHAPTER 011 Appendix

11.1 Methodology

11.2 About US

Contact Us

List of Tables

Table 1 Key Trends, Drivers, and Challenges Overview

Table 2 Research Scope and Segmentation

Table 3 Product Approvals

Table 4 Pipeline Products by Stage of Development

Table 5 Pipeline Products by Territory

Table 6 Pipeline Products by Territory

Table 7 Ongoing Clinical Trials

Table 8 Pipeline Products by Players

Table 9 Deep Brain Stimulators Market

Table 10 Deep Brain Stimulators by Products, 2020-2027 (US$ Mn)

Table 11 Deep Brain Stimulators by Application, 2020-2027 (US$ Mn)

Table 12 Deep Brain Stimulators by End User, 2020-2027 (US$ Mn)

Table 13 Number of Neurologists

Table 14 Deep Brain Stimulators by Region, 2020-2027 (US$ Mn)

Table 15 North America Deep Brain Stimulators by Country, 2020-2027 (US$ Mn)

Table 16 Europe Deep Brain Stimulators by Country, 2020-2027 (US$ Mn)

Table 17 Asia-Pacific Deep Brain Stimulators by Country, 2020-2027 (US$ Mn)

List of Figures

Fig.1 Market Snapshot (US$ Mn)

Fig.2 Key Segment Performance Snapshot

Fig.3 Global Deep Brain Stimulators PORTER’s Five Force Analysis

Fig.4 Deep Brain Stimulators – Pipeline Products by Stage of Development

Fig.5 Deep Brain Stimulators – Pipeline Products by Territory

Fig.6 Deep Brain Stimulators – Pipeline Products by Territory

Fig.7 Deep Brain Stimulators – Ongoing Clinical Trials

Fig.8 Global Deep Brain Stimulators Market – Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

Fig.9 Deep Brain Stimulators by Product – Market Overview (US$ Mn)

Fig.10 Deep Brain Stimulators by Products Share – 2021 & 2027 (%)

Fig.11 Single Channel Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

Fig.12 Dual Channel Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

Fig.13 Deep Brain Stimulators by Application – Market Overview (US$ Mn)

Fig.14 Deep Brain Stimulators by Application Share – 2021 & 2027 (%)

Fig.15 Parkinson’s Disease Application Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

Fig.16 Epilepsy Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

Fig.17 Essential Tremor Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

Fig.18 Obsessive Compulsive Disorder Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

Fig.19 Others Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

Fig.20 Deep Brain Stimulators by End User – Market Overview (US$ Mn)

Fig.21 Deep Brain Stimulators by End User Share – 2021 & 2027 (%)

Fig.22 Hospitals Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

Fig.23 Neurology Clinics Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

Fig.24 Others Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

Fig.25 Deep Brain Stimulators by Region– Market Overview (US$ Mn)

Fig.26 Deep Brain Stimulators by Region Share – 2021 & 2027 (%)

Fig.27 North America Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

Fig.28 Europe Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

Fig.29 Asia-Pacific Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

Fig.30 ROW Market Revenue Opportunity Forecast, 2020-2027 (US$ Mn)

Frequently Asked Questions

The deep brain stimulators size globally was valued at US$ 1.18 billion in 2021.

The deep brain stimulators market is expected to grow at a CAGR of 12.1% during the forecast period (2022-2027).

The introduction of technologically advanced deep brain stimulators and rising burden of neurological disorders are some of the major factors fueling deep brain stimulators market growth.

  • Product: Single Channel, Dual Channel
  • Application: Parkinson’s Disease, Epilepsy, Essential Tremor, Obsessive Compulsive Disorder, Others
  • End Users: Hospitals, Neurology Clinics, Others

Some of the leading companies in the deep brain stimulators industry are Abbott Laboratories (St. Jude Medical Inc.), Boston Scientific Corp., LivaNova Plc, and Medtronic Plc

$3,950

Can be used by individual purchaser only

$7,950

Can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Get in touch to find out about our multi-purchase discounts

reportstore@globaldata.com
Tel +44 (0) 20 7947 2960

Every customer’s requirement is unique. We understand that and can customize the report basis your exact research requirements pertaining to market insights, innovation insights, strategy and planning, and competitive intelligence. You can also avail the option of purchasing stand-alone sections of the report or request for a country specific report.

GDPR + CCPA Compliant

Personal and transaction information are kept safe from unauthorised use.

Recently Viewed Reports

Testimonial

“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.

GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”

Business Intelligence & Marketing Manager, SAL Heavy Lift

“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”

Market Analyst & Management, Liebherr-Werk

Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.

Head of Key Accounts, Saab AB

Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.

Marketing Intelligence Manager, Portugal Foods
Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.